Cyntellect has appointed David Voris as its vice president of finance and administration and CFO, the company said this week. Voris' appointment was effective Nov. 5.
Voris most recently served as the CFO of SynergEyes. Previously he had served as CFO of Laser Diagnostic Technologies from 1999 until its sale to Carl Zeiss Meditec in 2004.
Voris has also held various positions in finance and operations with companies including Alaris Medical Systems and Metracor Technologies. He began his career as a CPA at Deloitte & Touche.
BioSeek last week appointed Michael Venuti as CEO and board member. Venuti succeeds Peter Staple, who will continue his involvement with BioSeek as an investor and board member.
Venuti previously served as CEO of Discovery Partners International, a small
molecule-based drug discovery services company.
Prior to joining Discovery Partners, he served as general manager of Celera Genomics Group's South San Francisco site after its acquisition of Axys Pharmaceuticals. He also served as senior vice president of research andpreclinical development of Axys Pharmaceuticals prior to its acquisition by Celera.